SCHEMBL3755540

SCHEMBL3755540

[O-][N+]1(CCO)CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759401 0.86
SCHEMBL3754711 0.84
SCHEMBL11730650 0.82
SCHEMBL11732796 0.82
SCHEMBL3762932 0.79
SCHEMBL10656460 0.76
SCHEMBL1616368 0.76
SCHEMBL8846932 0.75 CDC25A (0.33)
SCHEMBL6044309 0.75
SCHEMBL665683 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2673242-B1 HYDROPHOBING DISPERSION GEL, METHOD FOR PRODUCING SAME, AND USE THEREOF FOR THE DEEP HYDROPHOBING OF MINERAL MATERIALS IONYS AG (DE) 2015-05-06 EP claimed
WO-2025088151-A1 ENHANCED METABOLIC MEDIUM FOR CULTURING PLURIPOTENT STEM CELLS UNIVERSITY OF COPENHAGEN (DK) 2025-05-01 WO disclosed
US-20150284583-A1 HYDROPHOBING DISPERSION GEL HAVING REDUCED ACTIVE INGREDIENT CONTENT, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR THE HYDROPHOBING OF MINERAL MATERIALS IONYS AG (DE) 2015-10-08 US disclosed
CN-104619676-A Hydrophobing dispersion gel having reduced active ingredient content, method for the production thereof, and use thereof for the hydrophobing of mineral materials IONYS AG 2015-05-13 CN disclosed
US-8084485-B2 6-(aminoalkyl)indazoles VITAE PHARMACEUTICALS, INC. (US) 2011-12-27 US disclosed
US-20100331287-A1 6-(Aminoalkyl)Indazoles VITAE PHARMACEUTICALS, INC. 2010-12-30 US disclosed
US-20100298328-A1 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes VITAE PHARMACEUTICALS, INC 2010-11-25 US disclosed
US-20080293701-A1 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors VITAE PHARMACEUTICALS, INC. 2008-11-27 US disclosed
WO-2007123718-A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES VITAE PHARMACEUTICALS, INC. (US) 2007-11-01 WO disclosed
WO-2007120523-A2 6-(AMINOALKYL)INDAZOLES VITAE PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed
US-20040152725-A1 Methods of treating cancer BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-08-05 US disclosed
EP-1408950-A2 METHODS OF TREATING CYTOKINE MEDIATED DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-04-21 EP disclosed
US-20030130309-A1 Methods of treating cytokine mediated diseases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-07-10 US disclosed
US-6525046-B1 Inhibits inflammatory cytokines such as interleukin-1 and tumor necrosis factor; 1-(5-(2-hydroxy-1,1-dimethyl-ethyl) -2-p-tolyl-2H-pyrazol-3-yl)-3- (4-(2- morpholin-4-yl-ethoxy)-naphthalen-1-yl)-urea BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-02-25 US disclosed
WO-2003005999-A2 METHODS OF TREATING CYTOKINE MEDIATED DISEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-01-23 WO disclosed
US-6500215-B1 TREATING WITH AMINE OXIDE TO MAKE TEXTILE MORE RECEPTIVE TO DYES SYBRON CHEMICALS, INC. 2002-12-31 US disclosed
WO-2002004742-A1 UTILITY OF SELECTED AMINE OXIDES IN TEXTILE TECHNOLOGY SYBRON CHEMICALS, INC. (US) 2002-01-17 WO disclosed
US-4009195-A FROM 1-ALKENES AND ACRYLIC ACID DERIVATIVES ROHM AND HAAS COMPANY (US) 1977-02-22 US disclosed
US-3994958-A OF 1-ALKENES AND ACRYLIC ACID DERIVATIVES ROHM AND HAAS COMPANY (US) 1976-11-30 US disclosed
US-3968148-A Copolymers of 1-alkenes and acrylic acid derivatives ROHM AND HAAS COMPANY (US) 1976-07-06 US disclosed